The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Angiodynamic Inc shares valued at $67,000 were purchased by Clemmer James C on Apr 08 ’24. At $6.70 per share, Clemmer James C acquired 10,000 shares. The insider’s holdings grew to 539,066 shares worth approximately $3.3 million following the completion of this transaction.
As published in a research note from Oppenheimer on April 05, 2024, Angiodynamic Inc [ANGO] has been rated up from a Perform to an Outperform and the price target has been revised to $12. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late September. As of April 17, 2023, Raymond James has decreased its “Strong buy” rating to a “an Outperform” for ANGO. Earlier on October 15, 2021, Canaccord Genuity upgraded its rating. Their new recommendation was “a Buy” for ANGO stock which previously was a “a Hold”.
Analyzing ANGO Stock Performance
During the last five days, there has been a drop of approximately -10.00%. Over the course of the year, Angiodynamic Inc shares have dropped approximately -21.94%. Shares of the company reached a 52-week high of $8.25 on 01/02/24 and a 52-week low of $5.26 on 03/25/24. A 50-day SMA is recorded $5.94, while a 200-day SMA reached $7.02. Nevertheless, trading volume fell to 0.81 million shares from 0.51 million shares the previous day.
Support And Resistance Levels for Angiodynamic Inc (ANGO)
According to the 24-hour chart, there is a support level at 6.03, which, if violated, would cause prices to drop to 5.93. In the upper region, resistance lies at 6.30. The next price resistance is at 6.47. RSI (Relative Strength Index) is 48.98 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.14, which suggests the price will decrease in the coming days. Percent R is at 79.55%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
